Balyasny Asset Management LLC Cutera Inc Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.39 - $4.79 $256,898 - $885,283	-184,819 Reduced 56.87%	140,184 $206,000
Q4 2023 Feb 14, 2024	SELL	$1.68 - $5.33 $1.09 Million - $3.47 Million	-650,920 Reduced 66.7%	325,003 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$6.02 - $20.05 $5.32 Million - $17.7 Million	884,085 Added 962.66%	975,923 $5.88 Million
Q2 2023 Aug 14, 2023	BUY	$14.14 - $27.07 $1.3 Million - $2.49 Million	91,838 New	91,838 $1.39 Million
Q4 2022 Feb 14, 2023	BUY	$39.63 - $51.65 $18.4 Million - $24 Million	465,326 New	465,326 $20.6 Million
Q2 2018 Aug 14, 2018	SELL	$35.45 - $55.85 $154,420 - $243,282	-4,356 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.25 - $54.6 $192,753 - $237,837	4,356 New	4,356 $219,000

11.4M

254K

407K

Ticker CUTR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,575,400
Market Cap $15.1M
Description
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.